NCT06798818View on ClinicalTrials.gov

Lung-cOnservative Liquid VEntilation for the Induction of Ultra-Rapid COOLing After Cardiac Arrest

NANot yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Cardiac ArrestPost Cardiac Arrest Syndrome
Interventions
DEVICE

Ultra-rapid therapeutic hypothermia induction by total liquid ventilation

Vent2Cool System is a targeted temperature management device used to induce ultra-rapid therapeutic hypothermia by total liquid ventilation.

Trial Locations (1)

75014

Hopital Cochin - Service de Medecine intensive et reanimation au 27 rue du Faubourg Saint-Jacques, Paris

All Listed Sponsors
lead

ORIXHA

INDUSTRY

NCT06798818 - Lung-cOnservative Liquid VEntilation for the Induction of Ultra-Rapid COOLing After Cardiac Arrest | Biotech Hunter | Biotech Hunter